PRESENTATION
Q3 2021 — Presentation
Q3 2021PDF · 34 pages3.8 MB
HSBC Holdings plc 3Q21 Results Presentation to Investors and Analysts -- 1 of 34 -- 3Q21 results Appendix Our purpose, values and ambition support the execution of our strategy 1 Opening up a world of opportunityOur purpose We get it done We value difference We succeed together We take responsibility Our values Our strategy To be the preferred international financial partner for our clients Our ambition Focus on our strengths Digitise at scale Energise for growth Transition to net zero -- 2 of 34 -- 3Q21 results Appendix 3Q21 highlights 2 2 Execution of strategy continues at pace 1 Reported PBT of $5.4bn up 76% vs. 3Q20; adjusted PBT of $6.0bn up 36% vs. 3Q20, primarily due to net ECL release of $0.7bn 4 Liquidity remains strong; CET1 ratio1 of 15.9%; share buyback of $2bn announced A reconciliation of reported results to adjusted results can be found on slide 16, the remainder of the presentation unless otherwise stated, is presented on an adjusted basis Figures throughout this presentation may be subject to rounding adjustments and therefore may not sum precisely to totals given in charts, tables or commentary 3 NII stabilising; strong reported fee growth, up 11% vs. 3Q20; good growth in Asia revenue despite adverse insurance market impacts; good profit contribution from all regions -- 3 of 34 -- 3Q21 results Appendix $bn 3Q21 2Q21 Δ Customer loans 1,040 1,045 (1)% Customer deposits 1,688 1,647 2 % Reported RWAs 839 862 (3)% CET1 ratio, % 15.9 15.6 0.3ppt TNAV per share, $ 7.81 7.81 — $m 3Q21 3Q20 Δ NII 6,610 6,646 (1)% Non interest income 5,591 5,728 (2)% Revenue 12,201 12,374 (1)% ECL 659 (823) >100% Costs (7,585) (7,612) 0 % Associates 721 459 57 % Adjusted PBT 5,996 4,398 36 % Significant items and FX translation (593) (1,324) 55 % Reported PBT 5,403 3,074 76 % Profit attributable to ordinary shareholders 3,543 1,359 >100% Reported EPS, $ 0.18 0.07 $0.11 Impact of sig items on reported EPS, $ (0.02) (0.05) $0.03 Reported RoTE2 (YTD, annualised), % 9.1 3.5 5.6ppt 3Q21 results summary 3 Adjusted PBT of $6.0bn up $1.6bn (36%) vs. 3Q20, primarily due to a net ECL release of $0.7bn vs. $0.8bn charge in 3Q20 Net interest income stable vs. 3Q20, with the global interest rate outlook improving Non-interest income down 2% vs. 3Q20, primarily due to the impact of certain volatile items; strong fee income growth of $0.3bn (10%) vs. 3Q20 across all businesses 3 Net ECL release of $0.7bn reflecting continued stability in economic conditions and better than expected levels of credit performance Costs of $7.6bn stable vs. 3Q20, with continued investment and increased tech spend offset by cost saves and lower performance related pay accrual Associate income of $0.7bn up $0.3bn (57%) vs. 3Q20, primarily due to higher profits from BoCom Lending down $6bn vs. 2Q21, including the repayment of $14bn of short-term IPO loans and mortgage growth of $7bn TNAV per share of $7.81, with profits offsetting dividends paid and adverse FX movements -- 4 of 34 -- 3Q21 results Appendix Business revenue growth drivers 4 Q3 Q1 Q2 Q3 Q4 64.4 Q2 Q1 2021 2020 2020 quarterly average: $34.5bn WPB YTD global WPB new-to-bank Premier customers, ‘000s 9M20 9M21 260 211 23% CMB & GBM Encouraging trends in global trade visible; 3Q21 trade balances of $79bn up $3bn (4%) QoQ and up $13bn (20%) YoY, with share gains in key markets: Hong Kong trade market share up 2.2ppt to 18.8%7 Singapore trade market share up 1.9ppt to 12.9%8 GBM revenue stabilising, comparing well against strong 2020 performance 3Q21 equities revenue of $0.3bn up $0.1bn (49%) YoY 3Q21 Securities Services Assets Under Custody up 23% YoY 3Q21 GBM RWAs decreased $20bn (7%) to $249bn YoY, with only a $105m (3%) decrease in revenue* * Including adverse XVAs of $84m ** Includes renewal and refinancing activity. Note, clients may elect not to draw down on approved limits 3Q21 Private Bank NNM of $3.9bn, with $3.1bn in Asia; AMG NNM of $4.3bn, with $1.3bn in Asia; reported Wealth Balances 4 of $1.6tn, up 10% YoY Insurance VNB up 8% QoQ and 59% YoY due to strong growth in Hong Kong onshore business Over 450 Pinnacle Wealth Planners in-force5 UK YTD gross mortgage market share of 8.6%; stock mortgage market share of 7.4% 6 Good new to bank customer acquisition e.g. in Premier Global CMB value of approved limits**, $bn Sustainability Helped our clients raise c.$170bn YTD in Green, Social and Sustainable bonds 9 , up 58% YoY Joint lead manager on £10bn UK Debt Management Office inaugural green gilt Partnership announced with Temasek to establish sustainable infrastructure debt financing platform Work underway on May 2021 AGM special resolution on climate commitments Geographic performance Pivot to Asia: strong revenue trends; 3Q21 revenue up $99m (2%) QoQ including adverse market impacts of $331m; up $143m (2%) YoY, including adverse insurance market impacts of $194m Good UK RFB performance; 3Q21 revenue up 6% YoY and up 2% QoQ; strong 3Q21 fee growth, fees up 25% YoY, up 13% QoQ -- 5 of 34 -- 3Q21 results Appendix 145 (167) (31) (99) 64 38 (47) 72 (81) 33 5 35 (92) (43) 142 (173) 5 3Q21 adjusted revenue performance 3Q21 revenue 3Q21 vs. 3Q20 Revenue by global business, $bn 3.7 3.2 5.6 5.4 (0.2) 3.5 3Q20 5.7 3.3 (0.1) 2Q21 3.4 (0.2) 3.6 3Q21 12.4 12.4 12.2 (1)% WPB Corporate Centre GBM CMB o/w XVAs and bid-offer adjustment: $(89)m o/w valuation differences: $(3)m (3)% 4% (3)% of which: GLCM Principal Investments Market impacts GLCM GTRF Credit and Lending Other Wealth (excl. Market impacts) Other $5,418m $3,374m $3,604m $(195)m $12,201m (1)% $2,206m $88m $465m $1,985m $458m $896m $1,520m $500m $185m $(40)m MSS WPB CMB GBM Corp. Centre Group Includes $(315)m impact of certain items Banking $1,659m Other $(128)m Personal Banking $3,067m -- 6 of 34 -- 3Q21 results Appendix NII stabilisation and fee growth across global businesses 6 92 60 (237) Corporate Centre 2Q21 WPB CMB GBM (109) 3Q21 12,395 12,201 Includes $(374)m of insurance market impacts 92 (426) NII 2Q21 Net fee income (374) Other income 3Q21 12,395 140 12,201 (52) Wealth GTRF GLCM MSS Other WPB Insurance market impacts All other income Adjusted revenue by global business, $m Adjusted revenue by income statement line, $m Strong fee growth across businesses; up $140m (4%) vs. 2Q21 and up $293m (10%) vs. 3Q20 Trade balances of $79bn up $3bn (4%) vs. 2Q21, and up $11bn (17%) vs. 4Q20; 3Q21 GTRF revenue up $68m (11%) vs. 3Q20 3Q21 average GLCM deposits of c.$770bn, up c.$20bn vs. 2Q21 and up c.$50bn vs. 3Q20 WPB down $237m (4%) vs. 2Q21, including $374m of adverse insurance market impacts CMB up $92m (3%), from increases in fees and interest income in Credit & Lending, GTRF and GLCM GBM up $60m (2%), with increased fee income in Securities Services and Banking -- 7 of 34 -- 3Q21 results Appendix 2,159 2,179 2,199 122bps 120bps 121bps 120bps 119bps (1)bp 7 Net interest income and margin (2) 2Q21 Asset mix 1 Liabilities and other 3Q21 120 119 Reported NIM progression, bps Reported NIM trend 3Q21 reported NII up $26m vs. 2Q21; adjusted NII was up $92m vs. 2Q21, primarily due to day count 3Q21 NIM of 1.19%, down 1bp vs. 2Q21, due to an adverse change in balance sheet mix NII has stabilised and the global interest rate outlook is improving, with the likelihood of 2022 policy rate rises having increased At 1H21, NII sensitivity to a +100bps parallel shift in yield curves would increase NII by $5.8bn in year 1 and by $8.2bn in year 510 Discrete quarterly reported NIM Average interest earning assets, $bn Reported NII, $m of which: significant items 6,584 6,610 18 3Q21 3Q20 (48) 1 4Q20 1Q21 2Q21 6,450 6,619 6,514 2,141 2,208 -- 8 of 34 -- 3Q21 results Appendix (0.31) (0.45) 0.17 0.11 8 Credit performance Adjusted ECL release/(charge) trend 3Q21 net ECL release of $0.7bn; continued low Stage 3 charges, Stage 1–2 release of $1.0bn, reflecting continued stability in economic and credit conditions We retain approximately $1.2bn (31%) of the $3.9bn Covid-19 related ECL uplift on the balance sheet Stage 3 loans and advances to customers as a % of total loans is 1.8%, stable vs. FY20 For FY21, expect a net release of ECL charges, with a possible further small net release in 4Q21, dependent on offsetting levels of Stage 3 charges Expect ECL charges to normalise in 2H22; medium-term ECL guidance range of 30bps to 40bps ECL release/(charge) as a % of average gross loans and advances ECL release/(charge) by stage, $bn ECL release/(charge) by geography, $m 1Q21 (823) 4Q20 (1,199) 3Q20 432 280 2Q21 659 3Q21 ECL, $m 3Q21 Stage 1-2 Stage 3 Total* Wholesale 0.6 (0.1) 0.5 Personal 0.4 (0.1) 0.3 Total 1.0 (0.2) 0.7 0.25 3Q21 2Q21 Hong Kong (37) (6) Asia ex. Hong Kong (68) (168) UK RFB 563 279 HSBC Bank plc 95 51 Mexico (12) (33) Other 118 157 Total 659 280 * Total includes an additional $0.1bn ECL charge attributed to other assets, which are not staged -- 9 of 34 -- 3Q21 results Appendix 9 Adjusted costs 263 340 Marketing, T&E 7,612 3Q20 Cost saves (629) 30 (31) PRP Other items incl. investment Tech spend13 7,585 3Q21 (0)% 2Q21 7,936 (134) Cost saves 4 Marketing, T&E 7,585 (377) PRP 37 Tech spend13 119 Other items incl. investment 3Q21 (4)% Operating expenses trend, $m 6,277 6,953 6,586 6,482 6,124 1,335 1,444 1,564 1,454 1,461 9,199 3Q21 3Q20 7,612 4Q20 802 8,150 2Q21 1Q21 7,936 7,585 UK bank levy Technology 11 Other Group costs 3Q21 vs. 3Q20, $m 3Q21 vs. 2Q21, $m 3Q21 costs of $7.6bn stable vs. 3Q20, with higher technology spend and investment, offset by cost saves of $0.6bn; 3Q21 cost saves had associated CTA of $0.4bn 3Q21 costs were down $0.4bn (4%) vs. 2Q21, primarily due to a lower performance-related pay (PRP) accrual and cost saves Programme saves to date of $2.6bn and associated CTA spend of $3.1bn Continue to expect total programme CTA spend of $7bn by FY22 We now expect FY21 and FY22 adjusted costs to be broadly stable vs. FY20 at c.$32bn12 excluding the bank levy, due to inflationary and performance- related pay pressure, investment and timing differences on acquisition and disposals in FY22 -- 10 of 34 -- 3Q21 results Appendix 10 Capital adequacy 3Q20 4Q20 1Q21 2Q21 3Q21 Common equity tier 1 capital, $bn 133.4 136.1 134.5 134.6 133.2 Reported risk-weighted assets, $bn 857.0 857.5 846.8 862.3 839.2 CET1 ratio, % 15.6 15.9 15.9 15.6 15.9 Leverage ratio exposure, $bn 2,857.4 2,897.1 2,930.2 2,968.5 2,964.8 Leverage ratio 1, % 5.4 5.5 5.4 5.3 5.2 Capital progression CET1 ratio of 15.9%, up 0.3ppt vs. 2Q21 Includes 3Q21 regulatory dividend accrual14 of $1.7bn (YTD $3.8bn) net of payment of 7¢ interim dividend Excludes c.25bps impact of announced share buyback expected in 4Q21 Reported RWAs of $839bn, down $23bn vs. 2Q21, primarily due to reductions in short- term IPO lending and FX movements Cumulative RWA saves of $93bn15, vs. FY22 target of $110bn Expect c.2% RWA inflation in 4Q21 from growth and regulatory impacts; $20bn-$35bn in FY22 from regulatory impacts Expected regulatory impacts on CET1 ratio include c.25bps each from: Reversal of software capitalisation benefit in 1Q22; France loss on disposal in 2Q22 Expect to be within target range of 14–14.5% CET1 ratio by FY22, primarily via growth and capital return CET1 ratio, % 0.4 0.3 2Q21 Profits Change in RWAs (0.0) FX translation differences (0.2) Other 15.9 (0.2) Dividend accrual 14 3Q21 15.6 134.6 862.3 133.2 CET1, $bn RWAs, $bn 839.2 (1.7) (1.2) (14.4) (8.7) 3.2 (1.7) -- 11 of 34 -- 3Q21 results Appendix Summary 11 1 More positive revenue outlook; growth in mortgages, trade and deposit balances — Stabilisation of NII — Strong fee growth 2 Continued strong cost control; seeing some inflation and performance related pay pressures. Expect c.$32bn costs for FY21 and FY2212, excluding the UK bank levy 4 Strong capital position, well placed to invest, grow and return capital to shareholders; $2bn share buyback announced * Illustrative impacts of IFRS 17 on our Insurance manufacturing business are detailed in the appendix 3 Interest rate outlook is constructive for returns; FY23 results onwards impacted by IFRS 17 * , remain committed to achieving a RoTE ≥10% over the medium-term16 -- 12 of 34 -- Appendix -- 13 of 34 -- 3Q21 results Appendix 13 Mainland China drawn risk exposure, at 30 June 2021 Mainland China drawn risk exposure17 183 1 10 43 46 51 2Q21 4Q19 4Q20 48 57 57 2Q21 4Q19 4Q20 Reported loans and advances to customers Reported customer deposits Mainland China drawn risk exposure (including Sovereigns, Banks and Customers) of $194bn comprising: Wholesale $183bn (of which 53% is onshore); Retail: $11bn. These amounts exclude Markets financing Gross loans and advances to customers of $51bn in mainland China (Wholesale: $40bn; Retail $11bn) At 2Q21 Stage 3 loan balances and change in ECL remained low HSBC is selective in its lending. HSBC’s onshore corporate lending market share is 0.14% as at 2Q2118 Wholesale lending analysis17, $bn Consumer Goods & Retail 34.7 11.9 19.6 Other Sectors Real Estate 19 Construction, Materials & Engineering 9.8 IT & Electronics 5.6 Public Utilities 4.8 Metals & Mining 4.7 Transportation 4.4 3.7 Pharma & Healthcare Corporate lending by sector* Wholesale lending by risk type: CRRs 1-3 4-6 7-8 9+ Total Sovereigns 47.1 0.0 47.2 Banks 32.7 0.2 32.9 NBFI 2.9 0.6 3.5 Corporates 65.4 33.2 0.1 0.6 99.3 Total 148.1 34.1 0.1 0.6 182.8 85 88 99 37 44 47 38 33 33 167 2 2Q19 4 3 163 2Q20 2Q21 183 NBFI Banks Sovereigns Corporates $ 194 bn $ 99 bn Credit cards and other consumer Wholesale Mortgages * The corporate lending by sector has been corrected from the version published on 02 August 2021. The 2Q21 $99bn Corporate lending balances includes a $3.5bn increase following an exposure classification adjustment. Prior period balances have not been restated c.18% of lending is to Foreign Owned Enterprises, c.39% of lending is to State Owned Enterprises, c.44% to Private sector owned Enterprises Corporate real estate19: 66% sits within CRR 1-3 (broadly equivalent to investment grade) Highly selective, focusing on top tier developers with strong performance track records Focused on Tier 1 and selected Tier 2 cities $bn $bn $bn -- 14 of 34 -- 3Q21 results Appendix 14 Mainland China incorporated Property company exposure Exposures to mainland China ultimate parent companies by booking location, $bn $bn Exposure to mainland China ultimate parent companies 14.7 Booked in mainland China 4.2 Booked elsewhere 10.5 - Of which: booked in Hong Kong 10.0 - Of which: booked in rest of Asia-Pacific 0.1 - Of which: booked in rest of world 0.4 0.4 10.0 0.1 4.2 Rest of world Hong Kong Other Asia Mainland China $14.7bn At 30 June 2021 Mainland China Real Estate exposures of $14.7bn do not include Hong Kong incorporated property company exposures of $4.9bn which have been booked in mainland China, but are a component of the $19.6bn of Real Estate exposure on the previous slide Real Estate business to mainland China is highly selective; focused on top tier developers with project lending concentrated in Tier 1 cities and Tier 2 cities. At 30 June 2021: 63% of exposure is to counterparties whose core business activity focuses on Residential Real Estate Development 66% of the book is categorised as investment grade, with 94% of exposures broadly equivalent to an external credit rating of BB- or above As at 30 September 2021, HSBC has no direct credit exposure to developers in the ‘Red’ category under the 3 red lines framework introduced to the sector We continue to monitor the potential second order impacts of recent developments Mainland China Real Estate exposures19 -- 15 of 34 -- 3Q21 results Appendix 15 Key financial metrics Reported results, $m 3Q21 2Q21 3Q20 NII 6,610 6,584 6,450 Other Income 5,402 5,981 5,477 Revenue 12,012 12,565 11,927 ECL 659 284 (785) Costs (7,989) (8,560) (8,041) Associates 721 771 (27) Profit before tax 5,403 5,060 3,074 Tax (1,161) (1,206) (1,035) Profit after tax 4,242 3,854 2,039 Profit attributable to ordinary shareholders 3,543 3,396 1,359 Profit attributable to ordinary shareholders excl. goodwill and other intangible impairment and PVIF 3,492 3,352 1,109 Basic earnings per share, $ 0.18 0.17 0.07 Diluted earnings per share, $ 0.17 0.17 0.07 Dividend per share (in respect of the period), $ — 0.07 — Return on avg. tangible equity (annualised), % 8.7 8.6 2.9 Return on avg. equity (annualised), % 8.0 7.8 3.2 Net interest margin (annualised), % 1.19 1.20 1.20 Adjusted results, $m 3Q21 2Q21 3Q20 NII 6,610 6,518 6,646 Other Income 5,591 5,877 5,728 Revenue 12,201 12,395 12,374 ECL 659 280 (823) Costs (7,585) (7,936) (7,612) Associates 721 769 459 Profit before tax 5,996 5,508 4,398 Cost efficiency ratio, % 62.2 64.0 61.5 ECL charge/(release) as a % of average gross loans and advances to customers (annualised) (0.25) (0.11) 0.31 Balance sheet, $m 3Q21 2Q21 3Q20 Total assets 2,968,791 2,976,005 2,955,935 Net loans and advances to customers 1,039,677 1,059,511 1,041,340 Adjusted net loans and advances to customers 1,039,677 1,045,360 1,058,541 Customer accounts 1,687,982 1,669,091 1,568,714 Adjusted customer accounts 1,687,982 1,647,240 1,592,284 Quarterly average interest-earning assets 2,207,960 2,198,953 2,141,454 Reported loans and advances to customers as % of customer accounts 61.6 63.5 66.4 Total shareholders’ equity 198,144 198,218 191,904 Tangible ordinary shareholders’ equity 157,711 157,985 152,260 Net asset value per ordinary share at period end, $ 8.70 8.69 8.41 Tangible net asset value per ordinary share at period end, $ 7.81 7.81 7.55 Capital, leverage and liquidity 3Q21 2Q21 3Q20 Reported risk-weighted assets, $bn 839.2 862.3 857.0 CET1 ratio, % 15.9 15.6 15.6 Total capital ratio (transitional), % 21.3 21.0 21.2 Leverage ratio, % 5.2 5.3 5.4 High-quality liquid assets (liquidity value), $bn 664 659 654 Liquidity coverage ratio, % 135 134 147 Share count, m 3Q21 2Q21 3Q20 Basic number of ordinary shares outstanding 20,201 20,223 20,173 Basic number of ordinary shares outstanding and dilutive potential ordinary shares 20,296 20,315 20,227 Quarterly average basic number of ordinary shares outstanding 20,213 20,227 20,166 -- 16 of 34 -- 3Q21 results Appendix 16 Reconciliation of reported and adjusted PBT $m 3Q21 2Q21 3Q20 Reported PBT 5,403 5,060 3,074 Revenue Currency translation — (130) 303 Customer redress programmes — — 48 Fair value movements on financial instruments 64 (45) (11) Restructuring and other related costs* 125 4 101 Currency translation of significant items — 1 6 189 (170) 447 ECL Currency translation — (4) (38) Operating expenses Currency translation — 89 (210) Customer redress programmes 7 27 3 Impairment of goodwill and other intangibles — — 57 Restructuring and other related costs 397 514 567 o/w: costs to achieve 390 499 557 Settlements and provisions in connection with legal and regulatory matters — — 3 Currency translation of significant items — (6) 9 404 624 429 Share of profit in associates and joint ventures Currency translation — (2) 24 Impairment of goodwill — — 462 — (2) 486 Total currency translation and significant items 593 448 1,324 Adjusted PBT 5,996 5,508 4,398 Memo: tax on significant items (at reported FX rates) (71) (77) (162) * Primarily comprises losses associated with RWA reduction commitments -- 17 of 34 -- 3Q21 results Appendix 17 Certain items included in adjusted revenue Certain items included in adjusted revenue highlighted in management commentary, $m 3Q21 2Q21 1Q21 4Q20 3Q20 Insurance manufacturing market impacts in WPB (40) 334 75 298 127 of which: Asia WPB insurance manufacturing market impacts (52) 271 (81) 249 156 Credit and funding valuation adjustments in GBM (49) 3 32 72 35 Legacy Credit in Corporate Centre (35) 6 9 3 28 Valuation differences on long-term debt and associated swaps in Corporate Centre (35) (27) (28) (12) (32) Argentina hyperinflation20 * (24) (42) (46) (42) (31) Bid-offer adjustment in GBM* 30 35 18 7 35 Total (153) 309 60 326 162 * Comparative figures have not been retranslated for foreign exchange movements -- 18 of 34 -- 3Q21 results Appendix (3)% 284 1,760 3,098 2,061 3Q20 3,089 2,293 223 4Q20 255 3,038 1Q21 3,062 171 2,088 2Q21 185 3,067 2,206 3Q21 (40) 75 127 298 334 3Q21 financial highlights Revenue $5.4bn (3)% (3Q20: $5.6bn) ECL $0.2bn >100% (3Q20: $(0.4)bn) Costs $(3.8)bn 0% (3Q20: $(3.8)bn) PBT $1.9bn 32% (3Q20: $1.4bn) RoTE21 17.2% 9.6ppt (9M20: 7.6%) 18 Wealth and Personal Banking Revenue performance, $m Wealth excl. market impacts Other Personal banking Balance sheet, $bn Reported Wealth Balances4, $bn 468 3Q21 2Q21 3Q20 484 804 831 482 845 3% 5% Customer lending Customer accounts 3Q21 vs. 3Q20 Revenue down $152m (3%) driven by adverse insurance market impacts of $167m, lower Markets Treasury revenue and lower interest rates, offset by higher Wealth (excl. market impacts) revenue ECL net release of $237m vs. $370m charge in 3Q20, as economic outlooks continued to improve resulting in Stage 1-2 releases Costs stable, with cost saves funding Asia Wealth investment and offsetting higher costs related to increasing business volumes Customer lending up $14bn (3%), mainly mortgages ($23bn, net of $3bn US HFS reclassification) and Lombard lending ($2bn), partially offset by a reduction of short-term IPO loans in HK in 3Q20 ($11bn) Customer accounts up $41bn (5%) across most markets, particularly in the UK ($31bn), partially offset by reclassification of customer accounts to liabilities held for sale in the US ($10bn) Wealth balances up $150bn (10%). Growth across all segments, particularly GPB client assets and Retail Wealth, driven by inflows and higher market levels 3Q21 vs. 2Q21 Revenue down $237m (4%) driven by adverse insurance market impacts of $374m and lower interest rates, offset by higher Wealth (excl. market impacts) revenue ECL net release of $237m vs. $32m release in 2Q21, as economic outlooks continued to improve resulting in Stage 1-2 releases Costs stable, with cost saves funding investment in Asia Wealth Customer lending down $2bn (<1%), driven by a reduction in short- term IPO loans in HK in 2Q21 ($9bn), largely offset by growth in mortgages ($7bn) Customer accounts up $14bn (2%), driven by growth across most markets, particularly in Private Banking ($6bn) and the UK ($4bn)Insurance manufacturing market impacts 371 1,639 317 373 450 2Q21 3Q20 295 457 427 470 418 437 469 315 3Q21 1,489 1,671 10% Global Private Banking Client Assets Retail Wealth Balances Premier and Jade deposits Asset Management third party distribution 5,570 5,370 5,661 5,655 5,418 -- 19 of 34 -- 3Q21 results Appendix 11% (1)% 19 Commercial Banking Balance sheet, $bn 943 436 500 386 1,482 3Q20 371 426 4Q20 857 543 452 458 1,459 1Q21 459 474 1,479 870 2Q21 1,520 896 3Q21 908 1,481 3,247 3,186 3,311 3,282 3,374 4% 3% Markets products, Insurance and Investments and Other GTRF GLCM Credit and Lending 3Q20 2Q21 3Q21 349 347 345 (0)% 3Q20 2Q21 3Q21 439 479 488 2% Customer lending Customer accounts 3Q21 financial highlights Revenue $3.4bn 4% (3Q20: $3.2bn) ECL $0.3bn >100% (3Q20: $(0.4)bn) Costs $(1.7)bn 0% (3Q20: $(1.7)bn) PBT $2.0bn 64% (3Q20: $1.2bn) RoTE21 11.6% 10.5ppt (9M20: 1.1%) Revenue performance, $m 3Q21 vs. 3Q20 Revenue up $127m (4%), the first YoY increase since the start of the pandemic, driven by higher fees across all products, growth in trade and deposit balances, notably in Asia, partially offset by the impact of lower rates ECL release of $272m vs. charge of $363m in 3Q20 due to release of Stage 1-2 provisions and limited Stage 3 charges Costs stable, driven by disciplined hiring and transformation saves more than offsetting our investment in technology Customer lending down $4bn (1%), as 2021 growth, notably in Asia, was more than offset by 4Q20 reductions reflecting the impact of Covid-19 Customer accounts up $50bn (11%), as customers raised and retained liquidity, notably in Asia and Europe 3Q21 vs. 2Q21 Revenue up $92m (3%), driven by growth across core products in interest income and fees across all regions, notably in Asia and the UK ECL release higher by $254m due to higher release of Stage 1-2 provisions and limited Stage 3 charges Costs down $77m (4%) as 2Q included higher performance-related pay, continued disciplined hiring more than offset investment spend Customer lending down $1bn with continued growth in trade (up $2bn) offset by repayments, notably $2bn of short term IPO loans in Asia and US corporate real estate of $1bn Customer accounts up $9bn (2%), reflecting continued liquidity in the market, notably in Asia and Europe -- 20 of 34 -- 3Q21 results Appendix 3Q21 financial highlights Revenue $3.6bn (3)% (3Q20: $3.7bn) ECL $0.1bn >100% (3Q20: $(0.1)bn) Costs $(2.3)bn 1% (3Q20: $(2.4)bn) PBT $1.4bn 13% (3Q20: $1.2bn) RoTE21 10.1% 3.2ppt (9M20: 6.9%) 20 Global Banking and Markets View of adjusted revenue 2Q21 3Q20 3Q21 249 269 253 (7)% (2)% Adjusted RWAs22, $bn 3,537 (40) 1,626 4Q20 1,927 1Q21 2,066 17 3Q20 35 1,575 2,473 1,617 168 1,921 1,646 3,604 (23) 2Q21 1,985 1,659 4,258 3,709 3Q21 3,544 2% MSS Other Banking Revenue performance, $m $m 3Q21 ∆3Q20 MSS 1,985 (4)% Securities Services 528 27 % Global Debt Markets 164 (46)% Global FX 772 (8)% Equities 348 49 % Securities Financing 222 (5)% XVAs (49) >(100)% Banking 1,659 2 % GTRF 180 2 % GLCM 465 1 % Credit & Lending 629 (8)% Capital Markets & Advisory 337 18 % Other 48 >100% GBM Other (40) >(100)% Principal Investments 88 66 % Other (128) >(100)% Net operating income 3,604 (3)% 3Q21 vs. 3Q20 Revenue down $0.1bn (3%): • Continued momentum in Equities, driven by wealth specifically in Asia and Europe and by strong primary activity, with continued volatility in Hong Kong and Shanghai stock exchanges • Strong quarter for Securities Services as fees increased and we grew Assets Under Custody by 23% • Strong performance in Leveraged and Acquisition Finance reflecting investment and strong activity, particularly in the US • GLCM grew fees reflecting payment volume growth, higher card spend and relative economic recovery • Global Debt Markets performance was impacted by higher flow activity in the prior year particularly in G10 derivatives, while 3Q21 was also impacted by lower capital employed for G10 derivatives • Banking Credit & Lending revenue and balances lower primarily due to strategic RWA actions ECL was a net release of $147m, reflecting Stage 1-2 releases due to improved economic outlook compared to a $103m charge in 3Q20 Costs down $23m (1%), primarily driven by cost saving initiatives which more than offset higher technology investment and performance-related pay accrual 3Q21 vs. 2Q21 Revenue higher by $60m (2%): • MSS up by 3% vs. prior quarter, primarily due to Securities Services and Equities, with lower Global Debt Markets • Good performance in M&A and US Leveraged and Acquisition Finance, partly offset by seasonal reduction in DCM client activity ECL net release of $147m, vs. a higher net release of $224m in 2Q21 -- 21 of 34 -- 3Q21 results Appendix 3Q21 financial highlights Revenue $(195)m (28)% (3Q20: $(152)m) ECL $3m (77)% (3Q20: $13m) Costs $191m (3)% (3Q20: $196m) Associates $708m 58% (3Q20: $449m) PBT $707m 40% (3Q20: $506m) RoTE21 5.4% 0.8ppt (9M20: 4.6%) 21 Corporate Centre Revenue performance, $m 4Q20 8 703 78 48 363 477 3Q20 150 767 675 136 38 1Q21 19 102 646 2Q21 103 66 539 3Q21 449 877 708 (8)% Associate income detail, $m 3Q20 4Q20 1Q21 2Q21 3Q21 Central Treasury (32) (12) (28) (27) (35) Legacy Credit 28 3 9 6 (35) Other (148) (138) (21) (65) (125) Of which: FX revaluation on Holdings balance sheet and net investment hedge (26) (4) 10 (1) (11) Total (152) (147) (40) (86) (195) Not included in Corporate Centre revenue: Markets Treasury revenue allocated to global businesses 672 603 798 510 524 Bank of Communications SABB Others 3Q21 vs. 2Q21 Revenue down $109m, primarily due to a loss on disposal of legacy portfolios in the US in 3Q21 and a one-off litigation cost in 3Q21 related to the sale of operations in Latin America Associates down $59m (8%), primarily due to lower share of profits from BoCom and SABB 3Q21 vs. 3Q20 Revenue down $43m, primarily due to a loss on disposal of legacy portfolios in the US in 3Q21, against favourable funding fair value adjustments in 3Q20 Associates up substantially ($259m, 58%), primarily due to higher share of profits from BoCom and BGF Adjusted RWAs22, $bn 53 3Q20 50 3735 53 2Q21 33 3Q21 86 85 90 2% (4)% Associates Other -- 22 of 34 -- 3Q21 results Appendix 22 Net interest margin supporting information 3Q20 4Q20 1Q21 2Q21 3Q21 % of 3Q21 Group NII % of 3Q21 Group AIEA The Hongkong and Shanghai Banking Corporation (HBAP) 1.44% 1.42% 1.40% 1.37% 1.35% 48% 42% HSBC Bank plc (NRFB) 0.50% 0.53% 0.51% 0.48% 0.47% 9% 22% HSBC UK Bank plc (UK RFB) 1.60% 1.60% 1.59% 1.56% 1.51% 24% 19% HSBC North America Holdings, Inc 0.83% 0.95% 0.96% 0.97% 0.90% 7% 9% Quarterly NIM by key legal entity Key rates (quarter averages), basis points 34 27 14 9 7 6 9 9 8 7 9 8 10 10 10 10 10 10 3Q20 4Q20 1Q21 3Q21 2Q21 4Q21 QTD* BoE Base Rate 1M HIBOR Fed effective rate Source: Bloomberg * At 22 October 2021 NII sensitivity to instantaneous change in yield curves (12 months) Change in Jul 2021 to Jun 2022 Currency USD HKD GBP EUR Other Total $m $m $m $m $m $m +25bps parallel 114 340 561 113 374 1,502 -25bps parallel (122) (393) (616) (83) (391) (1,605) +100bps parallel 369 1,354 2,053 532 1,464 5,772 -100bps parallel (224) (837) (2,257) (330) (1,542) (5,190) NII sensitivity to instantaneous change in yield curves (5 years), $m Change in Jul 2021 to Jun 2026 Year 1 Year 2 Year 3 Year 4 Year 5 Total +25bps parallel 1,502 1,806 1,976 2,098 2,158 9,540 -25bps parallel (1,605) (2,085) (2,042) (2,152) (2,235) (10,119) +100bps parallel 5,772 7,118 7,778 8,092 8,179 36,939 -100bps parallel (5,190) (6,924) (8,249) (8,892) (9,243) (38,498) At 30 June 2021 At 30 June 2021 -- 23 of 34 -- 3Q21 results Appendix 23 3Q21 vs. 2Q21 equity drivers Shareholders’ Equity, $bn Tangible Equity23, $bn TNAV per share, $ Basic number of ordinary shares, million As at 30 June 2021 198.2 158.0 7.81 20,223 Profit attributable to: 4.0 3.8 0.19 — Ordinary shareholders 3.5 3.8 0.19 — Other equity holders 0.5 — — — Dividends (1.9) (1.4) (0.07) — On ordinary shares (1.4) (1.4) (0.07) — On other equity instruments (0.5) — — — FX (2.0) (1.8) (0.09) — Actuarial gains/(losses) on defined benefit plans (0.0) (0.0) — — Fair value movements through ‘Other Comprehensive Income’ (0.2) (0.2) (0.01) — Of which: changes in fair value arising from changes in own credit risk 0.2 0.2 0.01 — Of which: Debt and Equity instruments at fair value through OCI (0.4) (0.4) (0.02) — Other 0.0 (0.7) (0.02) (22) As at 30 September 2021 198.1 157.7 7.81 20,201 Average basic number of shares outstanding during 3Q21: 20,213 million 3Q21 TNAV per share of $7.81 stable vs. 2Q21, mainly due to profits of 19¢ offset by adverse FX movements and dividends paid in the quarter $7.77 on a fully diluted basis 20,296 million on a fully diluted basis -- 24 of 34 -- 3Q21 results Appendix 3Q20 2Q21 3Q21 (2)% 24 Balance sheet – customer lending 347 468 1 349 240 214 1 484 482 345 212 1 1,059 1,045 1,040 (1)% Balances by global business, $bn WPB CMB GBM Corporate Centre Adjusted customer lending of $1,040bn down $6bn (1%) vs. 2Q21; primarily due to the repayment of $14bn of short-term IPO loans in Hong Kong WPB lending of $482bn decreased $2bn (<1%), $9bn of IPO lending repayments were partly offset by $7bn of mortgage growth, primarily in the UK and Hong Kong CMB lending of $345bn down $1bn (1%) with growth in trade (up $2bn) offset by repayments, notably $2bn of short term IPO loans in Asia and US CRE of $1bn Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America $(15)bn (5)% $(12)bn (2)% 2 2 $5bn 1% $(0)bn (1)% $5bn 2% $(0)bn (2)% $1bn 1% $1bn 3% $(6)bn (1)% Growth since 2Q21 o/w: mortgages o/w: mortgages $398bn $488bn $27bn $106bn $20bn $1,040bn $311bn $313bn $52bn -- 25 of 34 -- 3Q21 results Appendix 6% 3Q21 439 804 3Q20 349 479 1 831 2Q21 336 1 354 845 1 488 1,592 1,647 1,688 2% 25 Balance sheet – customer accounts Balances by global business, $bn Adjusted customer accounts of $1,688bn, up $41bn (2%) vs. 2Q21 WPB customer accounts of $845bn increased $14bn (2%), with broad-based growth across markets Wholesale customer accounts of $842bn increased $27bn (3%) as clients continue to build and retain liquidity WPB CMB Corporate centre GBM Balances by region, $bn Europe Asia MENA North America o/w: US Total o/w: Hong Kong o/w: UK Latin America $19bn 3% $4bn 2% $12bn 2% $3bn 3% $9bn 2% $15bn 2% $1bn 3% $41bn 2% $1bn 5% Growth since 2Q21 $667bn $771bn $42bn $179bn $28bn $1,688bn $533bn $537bn $114bn -- 26 of 34 -- 3Q21 results Appendix 26 IFRS 1724 - Summary IFRS 17 ‘Insurance Contracts’ IFRS 17 is effective from 1 January 2023 and will result in a number of changes compared to our current accounting policies No PVIF asset is recognised, rather the estimated future profit will be included in the measurement of the insurance contract liability as the contractual service margin (‘CSM’) and gradually recognised in revenue as services are provided over the duration of the insurance contract While the profit over the life of an individual contract will be unchanged, its emergence will be later under IFRS 17 Directly attributable costs will be incorporated in the CSM which will result in a reduction in reported operating expenses Our initial assumption (based on analysis of the expected 2022 position) is that the resultant accounting changes may result in a step down in the profitability of our insurance business by approximately two thirds on the transition, albeit with a range of expected outcomes. The RoE of the insurance business is not expected to be significantly impacted A similar impact is expected on the equity of the insurance business, primarily reflecting the elimination of the PVIF asset of $9.4bn, with an associated deferred tax liability of $1.7bn as at 1H21 and the creation of a CSM liability (the latter impacting tangible equity) No significant effects on the distribution of dividends from insurance subsidiaries nor on the bank’s regulatory capital are expected Insurance remains a core part of HSBC’s Wealth strategy. Continued growth in new business sales will support ongoing earnings growth from the new baseline after transition to IFRS 17 Insurance manufacturing Reported income statement, $m FY18 FY19 FY20 1H21 Revenue 2,040 2,711 1,977 1,555 Of which: VNB 1,117 1,225 776 563 Of which: market impacts (326) 124 102 413 Operating expenses (491) (505) (509) (280) Profit before tax 1,578 2,135 1,377 1,262 Items in table are non-additive VNB will no longer be recognised in the income statement under IFRS 17; instead revenue will emerge over the life of the contracts written The current intention is that VNB, Embedded Value and other return and performance metrics will continue to be provided as disclosures for comparability Reported Embedded value, $bn 7.7 2019 1H21 7.7 6.6 5.7 2018 7.7 2020 7.3 6.6 8.7 12.2 13.9 15.4 16.4 Other net assets PVIF and related deferred tax 25 -- 27 of 34 -- 3Q21 results Appendix 27 Insurance manufacturing reporting today Insurance as part of HSBC Group 11% 89% 1H21 Group adjusted PBT, $bn 9% 91% 1H21 Group ordinary shareholders’ equity, $bn Insurance Rest of Group Insurance Rest of Group $12.0bn $175.8bn Today HSBC reports Insurance Manufacturing results under IFRS 4: Insurance liabilities reflect current local market practices and regulatory approaches Value of New Business (VNB), a measure that recognises the expected profit to be earned over the lifetime of that business, is reported upfront as revenue when a new policy is written An intangible asset for the present value of in-force life insurance business (PVIF) is created on the balance sheet as permitted under the UK approach to bancassurance VNB and PVIF are calculated based on future expected investment return assumptions based on the assets held PVIF is incorporated in ordinary shareholders’ equity, but eliminated from tangible equity and CET1 calculations Current accounting treatment 0.4 0.9 1H21 1.3 of which: market impacts 1H21 Insurance PBT, $bn 7.7 1H21 16.4 8.7 1H21 reported Embedded value, $bn PVIF and related deferred tax Other net assets -- 28 of 34 -- 3Q21 results Appendix Total profit recognised over the lifetime of the contract is unchanged 28 Insurance manufacturing reporting under IFRS 17 Recognised profit over time Directional expected impact on tangible equity on transition IFRS 17 IFRS 4 End of contract Year 1 Time Loss of Day 1 profit recognition PVIF elimination IFRS 4 equity Restating assets IFRS 4 tangible equity Restating liabilities CSM IFRS 17 tangible equity PVIF Other net assets HSBC will adopt IFRS 17 from 1 January 2023, with 2022 comparatives restated Equity at transition will be impacted by the following: Elimination of PVIF intangible and the related deferred tax liability Establishing a Contractual Service Margin (‘CSM’) liability representing the unearned margins of the in-force business. It is calculated based on market consistent assumptions where future investments spreads are excluded Reclassification of certain assets to fair value, matching updated IFRS 17 liability measurement Revenue will no longer be booked up-front, but instead will be recognised as services are provided over the life of the contracts written Earnings will predominantly be generated by the unwind of the CSM of the in-force business and the emergence of asset spreads above the IFRS 17 discount rate Unlike current accounting where market impacts and changes in assumptions are reported immediately in profit or loss, under IFRS 17 these are spread over the remaining life of the impacted contracts Directional expected profit impact on 2022 comparatives IFRS 4 tangible PBT IFRS 4 PBT VNB and other PVIF movements CSM release Experience variance Attributable cost impact26 Economic impact IFRS 17 PBT -- 29 of 34 -- 3Q21 results Appendix 29 IFRS 4 vs. IFRS 17 – Key differences IFRS 4 IFRS 17 Profit emergence / recognition Value of new business (VNB) is reported as revenue on Day 1 Contractual service margin (CSM) will be reported as liability on Day 1 and recognised in revenue as services are provided (i.e. no Day 1 profit) Investment return assumptions (discount rate) VNB is calculated based on long-term investment return assumptions based on assets held. It therefore includes future investment margins expected to be earned in future, unlike under IFRS 17 CSM is calculated based on market consistent assumptions aligned with the characteristics of the liability Under the market consistent approach, future ‘investment spreads’ (the risk premia expected to be earned for taking equity risk, default risk, and liquidity risk) are excluded from reported earnings until they are actually earned in future time periods Expenses Total expenses to acquire and maintain the contract over its lifetime are included in the VNB calculation Expenses are recognised across operating expenses and fee expense as incurred, and the allowances for those costs released from the PVIF simultaneously Projected lifetime expenses that are directly attributable to acquiring and maintaining the portfolio of contracts are included in the CSM calculation, and amortised over the life of the contract as a deduction from Insurance Service revenue, not recognised as incurred Non-attributable costs are reported in operating expenses as incurred Balance sheet Assets mostly measured at amortised cost and fair value. Liabilities measured per local statutory/ regulatory requirements. An intangible asset for the present value of in-force life insurance business (PVIF) is created CSM balance will be recognised as a liability Assets and liabilities will be measured at current value PVIF asset will no longer be recognised, and existing PVIF asset will be eliminated to equity on transition Impact on key metrics Cost income ratio of HSBC may be impacted The combined impact of the changes in equity and profits will not significantly impact Group RoE We intend to introduce a new suite of IFRS 17 KPIs to help facilitate peer to peer comparisons -- 30 of 34 -- 3Q21 results Appendix 30 Glossary AIEA Average interest earning assets BGF Business Growth Fund, an associate of HSBC BoCom Bank of Communications Co. Limited, an associate of HSBC Bps Basis points. One basis point is equal to one-hundredth of a percentage point CET1 Common Equity Tier 1 Corporate Centre Corporate Centre comprises Central Treasury, our legacy businesses, interests in our associates and joint ventures, central stewardship costs and the UK bank levy CMB Commercial Banking, a global business CRR Customer Risk Rating CTA Costs to achieve C&L Credit and Lending DCM Debt Capital Markets ECL Expected credit losses. In the income statement, ECL is recorded as a change in expected credit losses and other credit impairment charges. In the balance sheet, ECL is recorded as an allowance for financial instruments to which only the impairment requirements in IFRS 9 are applied GBM Global Banking and Markets, a global business GLCM Global Liquidity and Cash Management Group HSBC Holdings plc and its subsidiary undertakings GTRF Global Trade and Receivables Finance HIBOR Hong Kong Interbank Offered Rate IFRS International Financial Reporting Standard LCR Liquidity coverage ratio Legacy credit A portfolio of assets including securities investment conduits, asset-backed securities, trading portfolios, credit correlation portfolios and derivative transactions entered into directly with monoline insurers MENA Middle East and North Africa MSS Markets and Securities Services NCI Non-controlling interests NII Net interest income NIM Net interest margin NNM Net new money NRFB Non ring-fenced bank in Europe and the UK OCI Other Comprehensive Income PBT Profit before tax Ppt Percentage points PVIF Present value of in-force insurance contracts SABB The Saudi British Bank, an associate of HSBC UK RFB HSBC UK, the UK ring-fenced bank, established July 2018 as part of ring fenced bank legislation RoTE Return on average tangible equity RWA Risk-weighted asset TNAV Tangible net asset value WPB Wealth and Personal Banking, a global business XVAs Credit and Funding Valuation Adjustments -- 31 of 34 -- 3Q21 results Appendix 31 Footnotes 1. Unless otherwise stated, regulatory capital ratios and requirements are based on the transitional arrangements of the Capital Requirements Regulation in force at the time. These include the regulatory transitional arrangements for IFRS 9 ‘Financial Instruments’. Following the end of the transition period after the UK’s withdrawal from the EU, any reference to EU regulations and directives (including technical standards) should be read as a reference to the UK’s version of such regulation and/or directive, as onshored into UK law under the European Union (Withdrawal) Act 2018 2. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric 3. WPB adjusted fees up $0.1bn (6%), CMB adjusted fees up $0.1bn (13%) and GBM adjusted fees up $0.1bn (11%) 4. Inclusive of Premier & Jade deposits and AUM, GPB client assets and AMG AUM 5. At 30 September 2021 6. Source: BoE. Stock mortgage market share at 30 August 2021. Gross market share is for August YTD 7. Source: HKMA at 31 August 2021; Hong Kong market share includes HASE 8. Source: MAS monthly statistical bulletin at 30 June 2021 9. Source: Dealogic, at 30 September 2021. Volume shows the full (non-apportioned) amount of financing raised in transactions in which HSBC led or co-led 10. Based on a static balance sheet at 30 June 2021 11. Technology costs in operating expenses trends include transformation saves and are presented on a net basis 12. Previous guidance for FY22 was $31.5bn including the bank levy on a constant currency basis at 30 June 2021 average FX rates 13. Technology cost increases in quarterly walks are presented on a gross basis (excl. saves) 14. Regulatory dividend accrual for the purposes of capital calculations. Over 9M21 we accrued 25.7¢, equal to 47.5% of reported EPS of 54¢, the mid-point of our 40%-55% targeted payout ratio range. In line with our dividend policy, we will retain the flexibility to adjust EPS for non-cash significant items. Additionally, in 2022, we expect to exclude from EPS the forecast loss on the sale of our retail banking operations in France 15. Cumulative RWA saves under our transformation programme as measured from 1 January 2020 to 30 September 2021, including $9.6bn of accelerated saves made over 4Q19 16. Medium term defined as three to four years from 1 January 2020 17. Mainland China drawn risk exposure. Retail drawn exposures represent retail lending booked in mainland China; Wholesale lending where the exposure is booked in mainland China or the ultimate parent/beneficial owner is in mainland China 18. Source: People’s Bank of China Financial Statistics Report H1 2021 19. Mainland China reported Real Estate exposures of $19.6bn at 1H21 comprises exposures to mainland China parent Real Estate companies of $14.7bn as shown in the table on slide 14, and $4.9bn of exposures not included in the table, but booked on mainland China entity balance sheets by corporates incorporated outside of mainland China (primarily Hong Kong incorporated companies); Real Estate is defined as lending to companies involved in Commercial Real Estate, Real Estate for Self Use and Real Estate Management & Service companies; Commercial Real Estate refers to lending that focuses on commercial development and investment in real estate and covers commercial, residential and industrial assets; Real Estate for Self Use refers to lending to a corporate or financial entity for the purchase or financing of a property which supports overall operations of a business i.e. a warehouse for an e-commerce firm 20. From 1st July 2018, Argentina was deemed a hyperinflationary economy for accounting purposes 21. YTD, annualised. RoTE by Global Business excludes significant items. RoTE methodology annualises Profits Attributable to Shareholders, including ECL, in order to provide a returns metric. RoTE by Global Business considers AT1 Coupons on an accruals basis, vs. Reported RoTE where it is treated on a cash basis 22. Data to reconcile components of reported RWAs to adjusted RWAs can be found in the ‘HSBC Holdings plc 3Q 2021 Datapack’ 23. Differences between shareholders’ equity and tangible equity drivers primarily reflect AT1 capital, goodwill and other intangibles and PVIF. ‘Profit Attributable to Ordinary shareholders’ differences primarily include goodwill and other intangibles impairment, PVIF movements and amortisation expense. ‘FX’ differences primarily include FX on goodwill and intangibles. ‘Other’ differences primarily include intangible additions and redemption of securities 24. The information in this slide is based on HSBC's current expectation of the manner in which the IFRS 17 standard will be implemented, which may be subject to further changes, as HSBC is currently in the process of implementing IFRS 17 and industry practice and interpretation of the standard are still developing. Additionally, the impact on the forecast future returns of HSBC's insurance business is dependent on the growth, duration and composition of its insurance contract portfolio. Therefore, the likely numerical impact of its implementation remains uncertain 25. Gross PVIF as reported at 1H21 is $9.4bn, and deferred tax liabilities arising on recognition of PVIF is $1.7bn 26. Reported operating expenses will reduce as expenses directly attributable to insurance contracts will be reported as a deduction from Insurance service revenue -- 32 of 34 -- 3Q21 results Appendix 32 Disclaimer Important notice The information, statements and opinions set out in this presentation and accompanying discussion (“this Presentation”) are for informational and reference purposes only and do not constitute a public offer for the purposes of any applicable law or an offer to sell or solicitation of any offer to purchase any securities or other financial instruments or any advice or recommendation in respect of such securities or other financial instruments. This Presentation, which does not purport to be comprehensive nor render any form of legal, tax, investment, accounting, financial or other advice, has been provided by HSBC Holdings plc (together with its consolidated subsidiaries, the “Group”) and has not been independently verified by any person. You should consult your own advisers as to legal, tax investment, accounting, financial or other related matters concerning any investment in any securities. No responsibility, liability or obligation (whether in tort, contract or otherwise) is accepted by the Group or any member of the Group or any of their affiliates or any of its or their officers, employees, agents or advisers (each an “Identified Person”) as to or in relation to this Presentation (including the accuracy, completeness or sufficiency thereof) or any other written or oral information made available or any errors contained therein or omissions therefrom, and any such liability is expressly disclaimed. No representations or warranties, express or implied, are given by any Identified Person as to, and no reliance should be placed on, the accuracy or completeness of any information contained in this Presentation, any other written or oral information provided in connection therewith or any data which such information generates. No Identified Person undertakes, or is under any obligation, to provide the recipient with access to any additional information, to update, revise or supplement this Presentation or any additional information or to remedy any inaccuracies in or omissions from this Presentation. Past performance is not necessarily indicative of future results. Differences between past performance and actual results may be material and adverse. Forward-looking statements This Presentation may contain projections, estimates, forecasts, targets, opinions, prospects, results, returns and forward-looking statements with respect to the financial condition, results of operations, capital position, strategy and business of the Group which can be identified by the use of forward-looking terminology such as “may”, “will”, “should”, “expect”, “anticipate”, “project”, “plan”, “estimate”, “seek”, “intend”, “target”, “believe”, "potential" and "reasonably possible" or the negatives thereof or other variations thereon or comparable terminology (together, “forward-looking statements”), including the strategic priorities and any financial, investment and capital targets and ESG target/commitments described herein. Any such forward-looking statements are not a reliable indicator of future performance, as they may involve significant stated or implied assumptions and subjective judgements which may or may not prove to be correct. There can be no assurance that any of the matters set out in forward-looking statements are attainable, will actually occur or will be realised or are complete or accurate. The assumptions and judgments may prove to be incorrect and involve known and unknown risks, uncertainties, contingencies and other important factors, many of which are outside the control of the Group. Actual achievements, results, performance or other future events or conditions may differ materially from those stated, implied and/or reflected in any forward-looking statements due to a variety of risks, uncertainties and other factors (including without limitation those which are referable to general market conditions, regulatory changes or due to the impact of the Covid-19 pandemic). Any such forward-looking statements are based on the beliefs, expectations and opinions of the Group at the date the statements are made, and the Group does not assume, and hereby disclaims, any obligation or duty to update, revise or supplement them if circumstances or management’s beliefs, expectations or opinions should change. For these reasons, recipients should not place reliance on, and are cautioned about relying on, any forward-looking statements. No representations or warranties, expressed or implied, are given by or on behalf of the Group as to the achievement or reasonableness of any projections, estimates, forecasts, targets, commitments, prospects or returns contained herein. Additional detailed information concerning important factors that could cause actual results to differ materially from this Presentation is available in our Annual Report and Accounts for the fiscal year ended 31 December 2020 filed with the Securities and Exchange Commission (the “SEC”) on Form 20-F on 24 February 2021 (the “2020 Form 20-F”), our 1Q 2021 Earnings Release furnished to the SEC on Form 6-K on 27 April 2021 (the “1Q 2021 Earnings Release”), our Interim Financial Report for the six months ended 30 June 2021 furnished to the SEC on Form 6-K on 2 August 2021 (the “2021 Interim Report”) and our 3Q 2021 Earnings Release, which we expect to furnish to the SEC on Form 6-K on 25 October 2021 (the “3Q 2021 Earnings Release”). Alternative Performance Measures This Presentation contains non-IFRS measures used by management internally that constitute alternative performance measures under European Securities and Markets Authority guidance and non-GAAP financial measures defined in and presented in accordance with SEC rules and regulations (“Alternative Performance Measures”). The primary Alternative Performance Measures we use are presented on an “adjusted performance” basis which is computed by adjusting reported results for the period-on-period effects of foreign currency translation differences and significant items which distort period-on-period comparisons. Significant items are those items which management and investors would ordinarily identify and consider separately when assessing performance in order to better understand the underlying trends in the business. Reconciliations between Alternative Performance Measures and the most directly comparable measures under IFRS are provided in our 2020 Form 20-F, our 1Q 2021 Earnings Release, our 2021 Interim Report and our 3Q 2021 Earnings Release, when filed, each of which are available at www.hsbc.com. Information in this Presentation was prepared as at 25 October 2021. -- 33 of 34 -- -- 34 of 34 --